Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Contemporary Clinical Trials|March 21, 2006
A reduced frequency visit schedule underreports adverse events that resulted in dose modifications or treatment discontinuations in HIV/AIDS clinical trials: ACTG DACS 207Michelle A Kendall, Janet W Andersen, Charles van der Horst
American Journal of Obstetrics and Gynecology|April 25, 2003
The predictive value of cytologic testing in women with the human immunodeficiency virus who have low-grade squamous cervical lesions: a substudy of a randomized, phase III chemoprevention trialWilliam R Robinson, Mindy B Luck, Michelle A Kendall, et al.
AIDS Research and Human Retroviruses|January 29, 2013
Perturbations of circulating levels of RANKL-osteoprotegerin axis in relation to lipids and progression of atherosclerosis in HIV-infected and -uninfected adults: ACTG NWCS 332/A5078 StudyTheodoros Kelesidis, Michelle A Kendall, Otto O Yang, et al.
Lipids in Health and Disease|March 21, 2013
Dysfunctional HDL and progression of atherosclerosis in HIV-1-infected and -uninfected adultsTheodoros Kelesidis, Otto O Yang, Michelle A Kendall, et al.
The Journal of Infectious Diseases|October 16, 2012
Biomarkers of microbial translocation and macrophage activation: association with progression of subclinical atherosclerosis in HIV-1 infectionTheodoros Kelesidis, Michelle A Kendall, Otto O Yang, et al.
Obstetrics and Gynecology|April 30, 2002
Isotretinoin for low-grade cervical dysplasia in human immunodeficiency virus-infected womenWilliam R Robinson, Janet Andersen, Teresa M Darragh, et al.
Medicine|June 1, 2018
Soluble levels of receptor for advanced glycation endproducts and dysfunctional high-density lipoprotein in persons infected with human immunodeficiency virus: ACTG NWCS332Theodoros Kelesidis, Michelle A Kendall, Ann Danoff, et al.
Inflammation|May 25, 2016
Soluble Levels of Receptor for Advanced Glycation Endproducts (RAGE) and Progression of Atherosclerosis in Individuals Infected with Human Immunodeficiency Virus: ACTG NWCS 332Ann Danoff, Michelle A Kendall, Judith S Currier, et al.
Clinical Trials (London, England)|March 8, 2022
Incorporating estimands into clinical trial statistical analysis plansMinhee Kang, Michelle A Kendall, Heather Ribaudo, et al.
Clinical Trials (London, England)|November 11, 2005
A reporting tool for real-time assessment of study data availabilityRonald J Bosch, Casey Pierce, John Spritzler, et al.
Pageof 4